[1] |
Beck A, Quirke KP, Gamelli RL, et al. Pediatric toxic epidermal necrolysis: Using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough[J]. J Burn Care Res,2015,36(1):167-177.
|
[2] |
Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin[J]. Science,1998,282(5388):490-493.
|
[3] |
刘藕根,邹叶青,李春明,等. 江西汉族人HLA-B*1502与卡马西平所致SJS/TEN相关性分析[J]. 临床皮肤科杂志,2014,43(5):272-274.
|
[4] |
Mawson AR, Eriator I, Karre S. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): Could retinoids play a causative role?[J]. Med Sci Monit,2015,21:133-143.
|
[5] |
López-García JS, Rivas Jara L, García-Lozano CI, et al. Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis[J]. Ophthalmology,2011,118(2):265-271.
|
[6] |
Vera LS, Gueudry J, Delcampe A, et al. In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Cornea, 2009,28(4):401-407.
|
[7] |
刘洁,曾跃平,龙琴,等. HLA-DR抗原在Stevens-Johnson综合征和中毒性表皮松解症患者急性期结膜上皮细胞中的表达[J]. 中国实用眼科杂志,2013,31(3):299-303.
|
[8] |
Barvaliya M, Sanmukhani J, Patel T, et al. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study[J]. J Postgrad Med,2011,57(2):115-119.
|
[9] |
Devi K, George S, Criton S, et al. Carbamazepine—the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: A study of 7 years[J]. Indian J Dermatol Venereol Leprol,2005,71(5):325-328.
|
[10] |
Gonzalo-Garijo MA, Cordobés-Duran C, Lamilla-Yerga AM, et al. Severe immediate reaction to nabumetone[J]. J Investig Allergol Clin lmmunol,2007,17(4):274-276.
|
[11] |
王倩,汪盛,张谊芝,等. Stevens-Johnson综合征和中毒性表皮坏死松解症77例临床分析[J]. 临床皮肤科杂志,2009,38(1):6-8.
|
[12] |
Shammas MC, Lai EC, Sarkar JS, et al. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids[J]. Am J Ophthalmol,2010,149(2):203-213 e202.
|
[13] |
Gregory DG. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases[J]. Ophthalmology,2011,118(5):908-914.
|
[14] |
Hsu M, Jayaram A, Verner R, et al. Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study[J]. Cornea,2012,31(12):1394-1402.
|
[15] |
Morales ME, Purdue GF, Verity SM, et al. Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN[J]. Am J Ophthalmol,2010, 150(4):505-510 e501.
|
[16] |
Di Pascuale MA, Espana EM, Liu DT, et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome[J]. Ophthalmology,2005,112(5):904-912.
|
[17] |
陈思扬,李莹. Stevens-Johnson综合征病理机制研究进展[J]. 国际眼科纵览,2011,35(1):22-25.
|